Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03698916Terminated

Delivra-Celecoxib 8% Cream and Osteoarthritis

Role: collaborator

NCT03882749Unknown

Delivra-Celecoxib 8% Cream and Osteoarthritis

Role: lead

NCT03393325Withdrawn

Tadalafil-Delivra and Raynaud's Phenomenon

Role: collaborator

NCT03653793Not ApplicableCompleted

LivRelief Varicose Veins Cream in the Treatment of Varicose Veins

Role: lead

NCT02193711Phase 3Completed

Delivra Joint Health Cream In The Treatment Of Pain Caused By Osteoarthritis Of The Knee

Role: lead

All 5 trials loaded